Centessa Pharmaceuticals (CNTA) Prepaid Assets (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Prepaid Assets of $15.7 million for Q1 2026, up 15.1% year-over-year from $13.6 million in Q1 2025, and up 757.09% quarter-over-quarter from $1.8 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) Prepaid Assets (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Prepaid Assets data on file, last reported at $15.7 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $15.7 million, up 15.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.7 million (up 15.1% YoY), and the FY2025 annual result was $1.8 million, down 82.54% from the prior year.
- Prepaid Assets improved to $15.7 million in Q1 2026 per CNTA's latest filing, from $1.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $22.7 million in Q3 2023 and troughed at $1.1 million in Q1 2022.
- A 5-year average of $7.6 million and a median of $3.3 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 1658.77% in 2023, then tumbled 89.89% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $3.3 million in 2022, then sank by 50.44% to $1.6 million in 2023, then soared by 545.53% to $10.5 million in 2024, then sank by 82.54% to $1.8 million in 2025, then jumped by 757.09% to $15.7 million in 2026.
- Business Quant data shows CNTA's Prepaid Assets at $15.7 million in Q1 2026, $1.8 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Mar 31, 2025 | 13.61 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 18.76 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 22.65 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 17.77 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 993,000.00 |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 444,000.00 |